Ticker: SKBI, Company: SKYSTAR BIO-PHARMACEUTICAL CO, Type: 8-K, Date: 2011-05-24
Original SEC Filing: Click here

---

Webplus: SKBI/20110524/8-K_1/2_EX-99.1/000.htm SEC Original: v223935_ex99-1.htm
NEWS RELEASE Skystar Bio-Pharmaceutical Reports First Quarter 2011 Results $7.0 Million Top Line; $0.27 Diluted EPS; Reiterates Fiscal 2011 Top Line Guidance range of $60 Million to $63 Million “ ” “ ” XI’AN, CHINA – May 23, 2011 — Skystar Bio-Pharmaceutical Company (NASDAQ:SKBI) ( First Quarter 2011 Highlights · Revenue increases 46% YoY to $7.0 million · Veterinary vaccines

---

---

Webplus: SKBI/20110524/8-K_1/1/000.htm SEC Original: v223935_8k.htm
FORM 8-K CURRENT REPORT Date of report (Date of earliest event reported): May 23, 2011 (May 23, 2011) SKYSTAR BIO-PHARMACEUTICAL COMPANY Nevada 001-34394 33-0901534 (State or other jurisdiction of incorporation or organization) (Commission File No.) (IRS Employer Identification No.) 4/F Building B Chuangye Square, No. 48 Keji Road, Gaoxin District, Xi’an, Shaanxi Province, P.R. China [Missing Graphic Reference] (8629) 8819-3188

---

Company Information:

Ticker: SKBI, Company: SKYSTAR BIO-PHARMACEUTICAL CO, Type: 8-K, Date: 2011-05-24CIK: 0001076939, Location: F4, SIC: 2834, SIC Desc: PHARMACEUTICAL PREPARATIONS
Business Phone & Address:
RM 10601, JIEZUO PLAZA, NO. 4, FENGHUI ROAD SOUTH, GAOXIN DISTRICT
XIAN PROVINCE